Trials / Completed
CompletedNCT05135468
A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)
A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Finasteride Spray (CU-40102) in Chinese Adult Male Patients With Androgenetic Alopecia (AGA)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 270 (actual)
- Sponsor
- Cutia Therapeutics（Wuxi）Co.,Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 41 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Clinical Study ,the mean change from baseline in vertex target area hair count (TAHC) after treatment for 24 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CU-40102 Spray | topical application, 1\~4 sprays each time, once daily |
Timeline
- Start date
- 2021-12-06
- Primary completion
- 2023-03-07
- Completion
- 2023-05-15
- First posted
- 2021-11-26
- Last updated
- 2023-08-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05135468. Inclusion in this directory is not an endorsement.